Cargando…
Hexosylceramides and Glycerophosphatidylcholine GPC(36:1) Increase in Multi-Organ Dysfunction Syndrome Patients with Pediatric Intensive Care Unit Admission over 8-Day Hospitalization
Glycero- and sphingo-lipids are important in plasma membrane structure, caloric storage and signaling. An un-targeted lipidomics approach for a cohort of critically ill pediatric intensive care unit (PICU) patients undergoing multi-organ dysfunction syndrome (MODS) was compared to sedation controls....
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145972/ https://www.ncbi.nlm.nih.gov/pubmed/33923179 http://dx.doi.org/10.3390/jpm11050339 |
_version_ | 1783697292270764032 |
---|---|
author | Leimanis-Laurens, Mara Wolfrum, Emily Ferguson, Karen Grunwell, Jocelyn R. Sanfilippo, Dominic Prokop, Jeremy W. Lydic, Todd A. Rajasekaran, Surender |
author_facet | Leimanis-Laurens, Mara Wolfrum, Emily Ferguson, Karen Grunwell, Jocelyn R. Sanfilippo, Dominic Prokop, Jeremy W. Lydic, Todd A. Rajasekaran, Surender |
author_sort | Leimanis-Laurens, Mara |
collection | PubMed |
description | Glycero- and sphingo-lipids are important in plasma membrane structure, caloric storage and signaling. An un-targeted lipidomics approach for a cohort of critically ill pediatric intensive care unit (PICU) patients undergoing multi-organ dysfunction syndrome (MODS) was compared to sedation controls. After IRB approval, patients meeting the criteria for MODS were screened, consented (n = 24), and blood samples were collected from the PICU at HDVCH, Michigan; eight patients needed veno-arterial extracorporeal membrane oxygenation (VA ECMO). Sedation controls were presenting for routine sedation (n = 4). Plasma lipid profiles were determined by nano-electrospray (nESI) direct infusion high resolution/accurate mass spectrometry (MS) and tandem mass spectrometry (MS/MS). Biostatistics analysis was performed using R v 3.6.0. Sixty-one patient samples over three time points revealed a ceramide metabolite, hexosylceramide (Hex-Cer) was high across all time points (mean 1.63–3.19%; vs. controls 0.22%). Fourteen species statistically differentiated from sedation controls (p-value ≤ 0.05); sphingomyelin (SM) [SM(d18:1/23:0), SM(d18:1/22:0), SM(d18:1/23:1), SM(d18:1/21:0), SM(d18:1/24:0)]; and glycerophosphotidylcholine (GPC) [GPC(36:01), GPC(18:00), GPC(O:34:02), GPC(18:02), GPC(38:05), GPC(O:34:03), GPC(16:00), GPC(40:05), GPC(O:36:03)]. Hex-Cer has been shown to be involved in viral infection and may be at play during acute illness. GPC(36:01) was elevated in all MODS patients at all time points and is associated with inflammation and brain injury. |
format | Online Article Text |
id | pubmed-8145972 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81459722021-05-26 Hexosylceramides and Glycerophosphatidylcholine GPC(36:1) Increase in Multi-Organ Dysfunction Syndrome Patients with Pediatric Intensive Care Unit Admission over 8-Day Hospitalization Leimanis-Laurens, Mara Wolfrum, Emily Ferguson, Karen Grunwell, Jocelyn R. Sanfilippo, Dominic Prokop, Jeremy W. Lydic, Todd A. Rajasekaran, Surender J Pers Med Article Glycero- and sphingo-lipids are important in plasma membrane structure, caloric storage and signaling. An un-targeted lipidomics approach for a cohort of critically ill pediatric intensive care unit (PICU) patients undergoing multi-organ dysfunction syndrome (MODS) was compared to sedation controls. After IRB approval, patients meeting the criteria for MODS were screened, consented (n = 24), and blood samples were collected from the PICU at HDVCH, Michigan; eight patients needed veno-arterial extracorporeal membrane oxygenation (VA ECMO). Sedation controls were presenting for routine sedation (n = 4). Plasma lipid profiles were determined by nano-electrospray (nESI) direct infusion high resolution/accurate mass spectrometry (MS) and tandem mass spectrometry (MS/MS). Biostatistics analysis was performed using R v 3.6.0. Sixty-one patient samples over three time points revealed a ceramide metabolite, hexosylceramide (Hex-Cer) was high across all time points (mean 1.63–3.19%; vs. controls 0.22%). Fourteen species statistically differentiated from sedation controls (p-value ≤ 0.05); sphingomyelin (SM) [SM(d18:1/23:0), SM(d18:1/22:0), SM(d18:1/23:1), SM(d18:1/21:0), SM(d18:1/24:0)]; and glycerophosphotidylcholine (GPC) [GPC(36:01), GPC(18:00), GPC(O:34:02), GPC(18:02), GPC(38:05), GPC(O:34:03), GPC(16:00), GPC(40:05), GPC(O:36:03)]. Hex-Cer has been shown to be involved in viral infection and may be at play during acute illness. GPC(36:01) was elevated in all MODS patients at all time points and is associated with inflammation and brain injury. MDPI 2021-04-24 /pmc/articles/PMC8145972/ /pubmed/33923179 http://dx.doi.org/10.3390/jpm11050339 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Leimanis-Laurens, Mara Wolfrum, Emily Ferguson, Karen Grunwell, Jocelyn R. Sanfilippo, Dominic Prokop, Jeremy W. Lydic, Todd A. Rajasekaran, Surender Hexosylceramides and Glycerophosphatidylcholine GPC(36:1) Increase in Multi-Organ Dysfunction Syndrome Patients with Pediatric Intensive Care Unit Admission over 8-Day Hospitalization |
title | Hexosylceramides and Glycerophosphatidylcholine GPC(36:1) Increase in Multi-Organ Dysfunction Syndrome Patients with Pediatric Intensive Care Unit Admission over 8-Day Hospitalization |
title_full | Hexosylceramides and Glycerophosphatidylcholine GPC(36:1) Increase in Multi-Organ Dysfunction Syndrome Patients with Pediatric Intensive Care Unit Admission over 8-Day Hospitalization |
title_fullStr | Hexosylceramides and Glycerophosphatidylcholine GPC(36:1) Increase in Multi-Organ Dysfunction Syndrome Patients with Pediatric Intensive Care Unit Admission over 8-Day Hospitalization |
title_full_unstemmed | Hexosylceramides and Glycerophosphatidylcholine GPC(36:1) Increase in Multi-Organ Dysfunction Syndrome Patients with Pediatric Intensive Care Unit Admission over 8-Day Hospitalization |
title_short | Hexosylceramides and Glycerophosphatidylcholine GPC(36:1) Increase in Multi-Organ Dysfunction Syndrome Patients with Pediatric Intensive Care Unit Admission over 8-Day Hospitalization |
title_sort | hexosylceramides and glycerophosphatidylcholine gpc(36:1) increase in multi-organ dysfunction syndrome patients with pediatric intensive care unit admission over 8-day hospitalization |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145972/ https://www.ncbi.nlm.nih.gov/pubmed/33923179 http://dx.doi.org/10.3390/jpm11050339 |
work_keys_str_mv | AT leimanislaurensmara hexosylceramidesandglycerophosphatidylcholinegpc361increaseinmultiorgandysfunctionsyndromepatientswithpediatricintensivecareunitadmissionover8dayhospitalization AT wolfrumemily hexosylceramidesandglycerophosphatidylcholinegpc361increaseinmultiorgandysfunctionsyndromepatientswithpediatricintensivecareunitadmissionover8dayhospitalization AT fergusonkaren hexosylceramidesandglycerophosphatidylcholinegpc361increaseinmultiorgandysfunctionsyndromepatientswithpediatricintensivecareunitadmissionover8dayhospitalization AT grunwelljocelynr hexosylceramidesandglycerophosphatidylcholinegpc361increaseinmultiorgandysfunctionsyndromepatientswithpediatricintensivecareunitadmissionover8dayhospitalization AT sanfilippodominic hexosylceramidesandglycerophosphatidylcholinegpc361increaseinmultiorgandysfunctionsyndromepatientswithpediatricintensivecareunitadmissionover8dayhospitalization AT prokopjeremyw hexosylceramidesandglycerophosphatidylcholinegpc361increaseinmultiorgandysfunctionsyndromepatientswithpediatricintensivecareunitadmissionover8dayhospitalization AT lydictodda hexosylceramidesandglycerophosphatidylcholinegpc361increaseinmultiorgandysfunctionsyndromepatientswithpediatricintensivecareunitadmissionover8dayhospitalization AT rajasekaransurender hexosylceramidesandglycerophosphatidylcholinegpc361increaseinmultiorgandysfunctionsyndromepatientswithpediatricintensivecareunitadmissionover8dayhospitalization |